Gilead Sciences

Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early
Motley Fool
Mon, 07/6/15 - 04:28 pm
Gilead Sciences
R/F/TAF
HIV
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)
Yahoo
Wed, 07/1/15 - 10:51 pm
Gilead Sciences
HIV
R/F/TAF
FDA
FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data
WSJ Pharmalot
Mon, 06/29/15 - 11:37 am
FDA
Gilead Sciences
hepatitis C
clinical trial data
Acquisitions May Fuel Gilead Sciences' Winning Ways
Investors.com
Sat, 06/27/15 - 12:05 pm
M&A
Gilead Sciences
Vertex Pharmaceuticals
Can Cambrex Keep Profits Healthy On Gilead Pact?
Investors.com
Sat, 06/27/15 - 11:38 am
Cambrex
Gilead Sciences
drug manufacturing
Gilead Is Set For Another Strong Quarter
Seeking Alpha
Fri, 06/26/15 - 08:07 pm
Gilead Sciences
China Rejects Gilead's Sovaldi Patent Application
Yahoo/Benzinga
Sun, 06/21/15 - 01:35 pm
China
Gilead Sciences
Sovaldi
patents
hepatitis C
Gilead Sciences: New Harvoni Prescriptions Decelerate
Barron's
Fri, 06/19/15 - 05:14 pm
Gilead Sciences
Harvoni
hepatitis C
prescription data
Despite insider sale, Receptos stock surges on takeover rumors
BioPharma Dive
Thu, 06/18/15 - 11:14 am
Receptos
M&A
AstraZeneca
Teva Pharmaceutical
Gilead Sciences
MS
multiple sclerosis
For Pharma, the Hollywood Model of Buying Pipeline Hits is not a Panacea
WSJ Pharmalot
Tue, 06/16/15 - 12:17 pm
JNJ
Gilead Sciences
hepatitis C
Pharmacyclics
No One Knows Why Gilead is Flying
Barron's
Fri, 06/12/15 - 09:30 am
Gilead Sciences
Gilead CEO's $21 Million Stock Sale
Barron's
Mon, 06/8/15 - 10:05 pm
Gilead Sciences
Pharma CEOs
John C. Martin
Gilead Sciences: What Game Theory Teaches Us About Hepatitis C
Barron's
Fri, 06/5/15 - 11:29 am
Gilead Sciences
hepatitis C
Gilead Sciences Will Do Some Deals, Surprise to the Upside
Barron's
Wed, 06/3/15 - 12:31 pm
Gilead Sciences
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Gilead on R&D hiring spree
BioPharma Dive
Fri, 05/29/15 - 10:42 am
Gilead Sciences
R&D
hirings
Will Gilead's Hepatitis C Dominance Collapse?
Investopedia
Fri, 05/29/15 - 10:21 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
JNJ
Gilead cuts ribbon on innovative new laboratory, announces additional $100m investment in Edmonton
Yahoo
Thu, 05/28/15 - 09:14 am
Gilead Sciences
GlobeImmune, Gilead Hep B drug fails in mid-stage study
Yahoo/Reuters
Wed, 05/27/15 - 09:53 am
GlobeImmune
Gilead Sciences
hepatitis B
GS-4774
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Gilead Sciences
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
drug pricing
Repatha
Praluent

Pages